|
Volumn 31, Issue 1, 2001, Pages 11-22
|
Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: Inhibition of monocyte transendothelial migration
|
Author keywords
Experimental autoimmune encephalomyelitis; Gene therapy; Gene engineered T cell; Monocyte migration; Nerve growth factor
|
Indexed keywords
CYTOKINE;
MYELIN BASIC PROTEIN;
NERVE GROWTH FACTOR;
NERVE GROWTH FACTOR RECEPTOR;
OVALBUMIN;
PROTEIN P75;
ALLERGIC ENCEPHALOMYELITIS;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
BLOOD BRAIN BARRIER;
CELL SECRETION;
CELL TRANSFER;
CONTROLLED STUDY;
DRUG MECHANISM;
GENETIC TRANSDUCTION;
IMMUNOMODULATION;
INFLAMMATORY INFILTRATE;
LEUKOCYTE MIGRATION INHIBITION;
MACROPHAGE;
MONOCYTE;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
RAT;
T LYMPHOCYTE;
ANIMALS;
CELL MOVEMENT;
ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL;
ENDOTHELIUM, VASCULAR;
GENE THERAPY;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
MONOCYTES;
NERVE GROWTH FACTOR;
RATS;
RATS, INBRED LEW;
RECEPTOR, NERVE GROWTH FACTOR;
T-LYMPHOCYTES;
TRANSFECTION;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0035132966
PISSN: 00142980
EISSN: None
Source Type: Journal
DOI: 10.1002/1521-4141(200101)31:1<11::AID-IMMU11>3.0.CO;2-G Document Type: Article |
Times cited : (169)
|
References (42)
|